Turenne Capital, Euro Capital and ILP Group completed an investment in Banook Group.

Private equity firms, Turenne Capital, Euro Capital and ILP Group completed an investment in Banook Group, a clinical research organization. Financial terms were not disclosed. “This operation is an important step in the acceleration of our development. The Banook Group places great importance in the improvement of the quality of life of millions of patients throughout the world. This is reflected in the company culture and our commitment to bringing science closer to people. We are excited to embark on this ambitious journey with our new partners,” Pascal Voiriot and Alexandre Durand-Salmon, Banook Group President and CEO, respectively.